- Home
- PRSO vs EVOK Comparison
PRSO vs EVOK Comparison
Compare PRSO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- EVOK
- Stock Information
- Founded
- PRSO 2008
- EVOK 2007
- Country
- PRSO United States
- EVOK United States
- Employees
- PRSO N/A
- EVOK N/A
- Industry
- PRSO Semiconductors
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- EVOK Health Care
- Exchange
- PRSO Nasdaq
- EVOK Nasdaq
- Market Cap
- PRSO 4.2M
- EVOK 4.3M
- IPO Year
- PRSO 2001
- EVOK 2013
- Fundamental
- Price
- PRSO $0.83
- EVOK $4.58
- Analyst Decision
- PRSO Strong Buy
- EVOK
- Analyst Count
- PRSO 2
- EVOK 0
- Target Price
- PRSO $3.38
- EVOK N/A
- AVG Volume (30 Days)
- PRSO 338.3K
- EVOK 1.2M
- Earning Date
- PRSO 11-12-2024
- EVOK 11-07-2024
- Dividend Yield
- PRSO N/A
- EVOK N/A
- EPS Growth
- PRSO N/A
- EVOK N/A
- EPS
- PRSO N/A
- EVOK N/A
- Revenue
- PRSO $12,727,000.00
- EVOK $8,617,036.00
- Revenue This Year
- PRSO $17.49
- EVOK $124.10
- Revenue Next Year
- PRSO $0.67
- EVOK $75.70
- P/E Ratio
- PRSO N/A
- EVOK N/A
- Revenue Growth
- PRSO N/A
- EVOK 100.35
- 52 Week Low
- PRSO $0.73
- EVOK $3.54
- 52 Week High
- PRSO $11.20
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- PRSO 29.83
- EVOK 39.65
- Support Level
- PRSO $0.92
- EVOK $4.03
- Resistance Level
- PRSO $1.17
- EVOK $6.09
- Average True Range (ATR)
- PRSO 0.23
- EVOK 0.58
- MACD
- PRSO -0.10
- EVOK -0.20
- Stochastic Oscillator
- PRSO 6.83
- EVOK 20.52
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.